Target Trial Emulations of Sodium-Glucose Cotransporter 2 Inhibitors in Systemic Lupus Erythematosus

被引:0
|
作者
Pope, Janet [1 ]
Karacabeyli, Derin [2 ]
Avina-Zubieta, J. Antonio [2 ]
机构
[1] Univ Western Ontario, London, ON, Canada
[2] Univ British Columbia, Arthrit Res Canada, Richmond, BC, Canada
关键词
EMPAGLIFLOZIN;
D O I
10.1002/art.43130
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:390 / 392
页数:3
相关论文
共 50 条
  • [1] Sodium-Glucose Cotransporter-2 Inhibitors and Nephritis Among Patients With Systemic Lupus Erythematosus
    Yen, Fu-Shun
    Wang, Shiow-Ing
    Hsu, Chih-Cheng
    Hwu, Chii-Min
    Wei, James Cheng-Chung
    JAMA NETWORK OPEN, 2024, 7 (06) : e2416578
  • [2] Sodium-Glucose Cotransporter 2 Inhibitors
    Erol, Cetin
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2024, 28 (05): : 216 - 216
  • [3] Sodium-Glucose Cotransporter 2 Inhibitors and Amputations
    Clements, Jennifer N.
    JAMA INTERNAL MEDICINE, 2019, 179 (03) : 451 - 452
  • [4] Heart and Sodium-Glucose Cotransporter 2 Inhibitors: A Sodium Dilemma
    Oyesomi, Elizabeth T.
    Tabrizchi, Reza
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (05) : 641 - 643
  • [5] Sodium-glucose cotransporter inhibitors for diabetes
    Isaji, Masayuki
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (04) : 285 - 292
  • [6] Sodium-glucose cotransporter 2 inhibitors: are they ready for prime time in the management of lupus nephritis?
    Wagner, Benjamin R.
    Rao, Panduranga S.
    CURRENT OPINION IN RHEUMATOLOGY, 2024, 36 (03) : 163 - 168
  • [7] Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling
    Husam M. Salah
    Subodh Verma
    Carlos G. Santos-Gallego
    Ankeet S. Bhatt
    Muthiah Vaduganathan
    Muhammad Shahzeb Khan
    Renato D. Lopes
    Subhi J. Al’Aref
    Darren K. McGuire
    Marat Fudim
    Journal of Cardiovascular Translational Research, 2022, 15 : 944 - 956
  • [8] Sodium-glucose cotransporter 2 inhibitors and emphysematous cystitis
    Dubin, Ina
    Glick, Yair
    Schattner, Ami
    POSTGRADUATE MEDICAL JOURNAL, 2024, 100 (1190) : 946 - 947
  • [9] CARDIOPROTECTIVE MECHANISMS OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS
    Mkrtumyan, Ashot M.
    Markova, Tatyana N.
    Mishchenko, Nadezhda K.
    DIABETES MELLITUS, 2021, 24 (03): : 291 - 299
  • [10] Benefits and Complications of Sodium-Glucose Cotransporter 2 Inhibitors
    Sangiovanni, Ryan J.
    DeVee, Carley E.
    US PHARMACIST, 2019, 44 (02) : HS9 - HS12